Changes in PCSK 9 and apolipoprotein B100 in Niemann–Pick disease after enzyme replacement therapy with olipudase alfa

被引:0
|
作者
Bethanie Garside
Jan Hoong Ho
See Kwok
Yifen Liu
Shaishav Dhage
Rachelle Donn
Zohaib Iqbal
Simon A. Jones
Handrean Soran
机构
[1] University of Manchester,Lipid Research Group, Division of Cardiovascular Sciences
[2] Manchester University NHS Foundation Trust,Cardiovascular Trials Unit, Manchester Royal Infirmary
[3] University of Manchester,Faculty of Biology, Medicine and Health
[4] Manchester University NHS Foundation Trust,Manchester Centre for Genomic Medicine, St Marys Hospital
关键词
Acid sphingomyelinase deficiency; Apolipoprotein B100; Proprotein convertase subtilisin/klexin type 9; Tumour necrosis factor α; Low density lipoprotein cholesterol; Enzyme replacement therapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 33 条
  • [1] Changes in PCSK 9 and apolipoprotein B100 in Niemann-Pick disease after enzyme replacement therapy with olipudase alfa
    Garside, Bethanie
    Ho, Jan Hoong
    Kwok, See
    Liu, Yifen
    Dhage, Shaishav
    Donn, Rachelle
    Iqbal, Zohaib
    Jones, Simon A.
    Soran, Handrean
    ORPHANET JOURNAL OF RARE DISEASES, 2021, 16 (01)
  • [3] Reversal of interstitial lung disease after olipudase alfa enzyme replacement therapy in adults with acid sphingomyelinase deficiency
    Bonella, Francesco
    Wasserstein, Melissa
    Giugliani, Roberto
    Lachmann, Robin
    Noth, Imre
    Scarpa, Maurizio
    Wuyts, Wim A.
    Aguiar, Mario
    Armstrong, Nicole M.
    Jessel, Andreas
    Kumar, Monica
    Waters, Sara
    Berger, Kenneth I.
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [4] Apolipoprotein B100 metabolism in autosomal-dominant hypercholesterolemia related to mutations in PCSK9
    Ouguerram, K
    Chetiveaux, M
    Zair, Y
    Costet, P
    Abifadel, M
    Varret, M
    Boileau, C
    Magot, T
    Krempf, M
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2004, 24 (08) : 1448 - 1453
  • [5] APOLIPOPROTEIN B-100 DECREASES IN ASSOCIATION WITH REDUCTION IN PCSK9 CONCENTRATION IN ACID SPHINGOMYELINASE DEFICIENCY FOLLOWING ENZYME REPLACEMENT THERAPY
    Garside, B.
    Liu, Y.
    Neelamekam, S.
    Ho, J. Hoong
    Dhage, S.
    Kwok, S.
    Jones, S. A.
    Soran, H.
    ATHEROSCLEROSIS, 2019, 287 : E29 - E30
  • [6] APOLIPOPROTEIN B-100 DECREASES IN ASSOCIATION WITH REDUCTION IN PCSK9 CONCENTRATION IN ACID SPHINGOMYELINASE DEFICIENCY FOLLOWING ENZYME REPLACEMENT THERAPY
    Garside, Bethanie
    Liu, Yifen
    Neelamekam, Sasi
    Ho, Jan Hoong
    Dhage, Shaishav
    Kwok, See
    Jones, Simon A.
    Soran, Handrean
    ATHEROSCLEROSIS SUPPLEMENTS, 2019, 38 : E2 - E2
  • [7] Preclinical studies of enzyme replacement therapy in the mouse model of Types A and B Niemann-Pick disease.
    Schuchman, EH
    Miranda, SRP
    He, X
    Simonaro, CM
    Desnick, RJ
    AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (04) : 427 - 427
  • [8] REPLACEMENT THERAPY FOR INHERITED ENZYME DEFICIENCY - LIVER ORTHOTOPIC TRANSPLANTATION IN NIEMANN-PICK DISEASE TYPE-A
    DALOZE, P
    DELVIN, EE
    CORMAN, JL
    BETTEZ, P
    TOUSSI, T
    AMERICAN JOURNAL OF MEDICAL GENETICS, 1977, 1 (02): : 229 - 239
  • [9] Sustained Improvement of Interstitial Lung Disease Following Enzyme Replacement Therapy with Olipudase Alfa in Children and Adults with Chronic Acid Sphingomyelinase Deficiency
    Berger, K. I.
    Scarpa, M.
    Diaz, G. A.
    Giugliani, R.
    Lachmann, R.
    Wasserstein, M. P.
    Bonella, F.
    Walsh, S. L.
    Wuyts, W. A.
    Jessel, A.
    Rawlings, A. M.
    Kumar, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [10] ROLE OF LIPOPROTEIN(A) APOLIPOPROTEIN B100 AND ANGIOTENSIN CONVERTING ENZYME GENE POLYMORPHISM IN CORONARY ARTERY DISEASE IN INDIANS
    Tewari, Satyendra
    Goel, P. K.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E1356 - E1356